US Diabetes Market Poised for $79 Billion by 2031, Driven by CGM and GLP-1 Dominance
The US Diabetes Market is a dynamic and expanding sector, continuously evolving to address the rising prevalence of diabetes and obesity across the nation. This market encompasses a broad range of products and services, including monitoring devices, treatment therapies, and advanced drug delivery systems. The overall U.S. diabetes monitoring, treatment, and drug delivery market was valued at nearly $48 billion in 2024 and is expected to increase to $79 billion by 2031, exhibiting a robust Compound Annual Growth Rate (CAGR) of 7.3% over the forecast period (2024-2031). This significant growth underscores the ongoing demand for innovative and effective solutions for diabetes management.
The market's performance is largely shaped by technological advancements, favorable reimbursement policies, and a shift towards more integrated and patient-centric care.
Key Market Trends and Drivers:
Dominance of Insulin and GLP-1 Market: The largest and fastest-growing segment in the US diabetes care market is the insulin and GLP-1 (Glucagon-Like Peptide-1) market. GLP-1 receptor agonists, such as Ozempic®, have seen rapid growth due to their effectiveness in managing both type 2 diabetes and obesity, two interconnected chronic conditions with increasing prevalence. This demand for more effective and innovative treatment options is a primary driver.
Surge in Continuous Glucose Monitoring (CGM) Adoption: Continuous Glucose Monitoring (CGM) systems are a major growth driver. Dexcom, for instance, holds a dominant position with its G6® and G7 devices. Medicare's expanded CGM coverage to all insulin-using beneficiaries has significantly broadened the eligible patient pool, driving widespread adoption of these real-time monitoring devices which offer enhanced glucose control and improved patient outcomes.
Rise of Smart Reusable Insulin Pens: The market for smart reusable insulin pens is growing steadily. These devices offer advanced digital features that help individuals manage insulin doses more efficiently, providing better control and convenience. While priced higher than traditional models, their advanced technology is expected to lead to more consistent and improved diabetes management, increasing demand.
Integration with Smartphone Ecosystems: The increasing integration of diabetes devices with smartphone ecosystems is boosting patient engagement. This allows for seamless data tracking, remote monitoring, and personalized insights, making diabetes management more convenient and accessible.
Shift Towards Value-Based Care: The US healthcare system's move towards value-based care incentivizes remote monitoring penetration and integrated solutions. This shift encourages the adoption of technologies that can demonstrate improved patient outcomes and cost efficiencies, driving demand for advanced diabetes management tools.
High Prevalence of Diabetes: With an epidemiological backdrop of 38.4 million Americans living with diabetes, the sheer volume of patients continuously propels the demand for both monitoring and management solutions. The economic burden of diabetes, estimated at $413 billion in 2022, further highlights the need for effective medical technology to improve control and reduce costs.
Growth in Homecare Settings: The homecare segment dominated the US diabetes devices market with a 67.34% market share in 2024. This reflects the preference for convenient, self-managed care, supported by accessible devices and consumables.
E-commerce Expansion: E-commerce sales of diabetes devices are forecast to expand at a CAGR of 7.82% through 2030, offering increased accessibility and competitive pricing.
Challenges in the market include the high associated costs of certain therapies and devices, limitations in insurance coverage for some innovative solutions, sustainability pressure on single-use plastic pens, and stringent regulatory requirements. However, the overarching need for effective diabetes management solutions, combined with ongoing technological advancements and supportive policy changes, ensures the continued robust growth of the US Diabetes Market.
About Market Research Future (MRFR)
Market Research Future (MRFR) is a global market research firm that provides comprehensive insights into market trends, drivers, challenges, and opportunities. We offer a broad range of market intelligence reports and consulting services to help businesses and enterprises in various industries make informed decisions.
Media Contact:
Market Research Future (MRFR)Phone: +1-646-845-9312
Email: contact@marketresearchfuture.com
Website: marketresearchfuture